effective Search Results


95
Transnetyx transnetyx genetic monitoring service
Transnetyx Genetic Monitoring Service, supplied by Transnetyx, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transnetyx genetic monitoring service/product/Transnetyx
Average 95 stars, based on 1 article reviews
transnetyx genetic monitoring service - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
Alluxa Inc half maximum fwhm bandpass filter bpf
Half Maximum Fwhm Bandpass Filter Bpf, supplied by Alluxa Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/half maximum fwhm bandpass filter bpf/product/Alluxa Inc
Average 95 stars, based on 1 article reviews
half maximum fwhm bandpass filter bpf - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

96
Proteintech gapdh
Gapdh, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gapdh/product/Proteintech
Average 96 stars, based on 1 article reviews
gapdh - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

94
MedChemExpress pgc 1α
Pgc 1α, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgc 1α/product/MedChemExpress
Average 94 stars, based on 1 article reviews
pgc 1α - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
Evotec Inc neurodegeneration
Neurodegeneration, supplied by Evotec Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurodegeneration/product/Evotec Inc
Average 92 stars, based on 1 article reviews
neurodegeneration - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

95
Chem Impex International glycerol chem impex
Glycerol Chem Impex, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glycerol chem impex/product/Chem Impex International
Average 95 stars, based on 1 article reviews
glycerol chem impex - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

92
Boster Bio ppargc1a
FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, <t>PPARGC1A</t> and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.
Ppargc1a, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppargc1a/product/Boster Bio
Average 92 stars, based on 1 article reviews
ppargc1a - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

95
TargetMol compound library
FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, <t>PPARGC1A</t> and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.
Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound library/product/TargetMol
Average 95 stars, based on 1 article reviews
compound library - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
TargetMol compounds l2130
FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, <t>PPARGC1A</t> and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.
Compounds L2130, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compounds l2130/product/TargetMol
Average 93 stars, based on 1 article reviews
compounds l2130 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Boster Bio anti pgc1α
FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, <t>PPARGC1A</t> and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.
Anti Pgc1α, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pgc1α/product/Boster Bio
Average 92 stars, based on 1 article reviews
anti pgc1α - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

95
Chem Impex International carboxyphenol ba
FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, <t>PPARGC1A</t> and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.
Carboxyphenol Ba, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carboxyphenol ba/product/Chem Impex International
Average 95 stars, based on 1 article reviews
carboxyphenol ba - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

Image Search Results


FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, PPARGC1A and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.

Journal: Pathology international

Article Title: FHL1: A novel diagnostic marker for papillary thyroid carcinoma.

doi: 10.1111/pin.13467

Figure Lengend Snippet: FIGURE 5 The expression of FHL1, BCL2, TLE1, KIT, PPARGC1A and GHR in papillary thyroid carcinoma (PTC) and the control group. FHL1 showed strong positivity in the nuclei and to a lesser extent in the cytoplasm of normal thyroid tissues adjacent to the tumour (the control group), but is not present in the PTC tissues. (p < 0.01). There was no significant difference in the expression of BCL2 between PTC and normal thyroid tissues (p > 0.05). The results showed that TLE1, KIT, PPARGC1A, and GHR were absent in both tumor and normal tissues. (magnification ×200). FHL1, four and a half LIM domains 1.

Article Snippet: Slides were immunostained with monoclonal antibodies against the BCL2 antigen (clone SP66, Maixin), CD117/C‐kit antigen (clone YR145, Maixin), and with monoclonal antibodies against the FHL1 (10991‐1‐AP, Proteintech Group, Inc.), PPARGC1A (Boster, China), and TLE1 antigen (Maixin).

Techniques: Expressing, Control